Remibrutinib (LOU064) Versus Placebo in Patients with Chronic Spontaneous Urticaria: A Randomised, Double-Blind, Phase 2b Dose-Finding Study

Autor:	Marcus Maurer, William Berger, Ana Giménez-Arnau, Koremasa Hayama, Vipul Jain, Adam Reich, Sibylle Haemmerle, Karine Lheritier, Pauline Walsh, Summer Xia, Julian Storim
Rok vydání:	2021
Zdroj:	SSRN Electronic Journal.
ISSN:	1556-5068
DOI:	10.2139/ssrn.3968885
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2d29862bcf7bd69f30942036ed2100f0 https://doi.org/10.2139/ssrn.3968885 Zobrazit plný text záznamu